Cargando…

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Detalles Bibliográficos
Autores principales: Elias, D., Vever, H., Lænkholm, A.-V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., Ditzel, H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056636/
https://www.ncbi.nlm.nih.gov/pubmed/31712727
http://dx.doi.org/10.1038/s41388-019-1096-8
_version_ 1783503505714053120
author Elias, D.
Vever, H.
Lænkholm, A.-V.
Gjerstorff, M. F.
Yde, C. W.
Lykkesfeldt, A. E.
Ditzel, H. J.
author_facet Elias, D.
Vever, H.
Lænkholm, A.-V.
Gjerstorff, M. F.
Yde, C. W.
Lykkesfeldt, A. E.
Ditzel, H. J.
author_sort Elias, D.
collection PubMed
description
format Online
Article
Text
id pubmed-7056636
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70566362020-03-06 Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy Elias, D. Vever, H. Lænkholm, A.-V. Gjerstorff, M. F. Yde, C. W. Lykkesfeldt, A. E. Ditzel, H. J. Oncogene Correction Nature Publishing Group UK 2019-11-11 2020 /pmc/articles/PMC7056636/ /pubmed/31712727 http://dx.doi.org/10.1038/s41388-019-1096-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Elias, D.
Vever, H.
Lænkholm, A.-V.
Gjerstorff, M. F.
Yde, C. W.
Lykkesfeldt, A. E.
Ditzel, H. J.
Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
title Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
title_full Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
title_fullStr Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
title_full_unstemmed Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
title_short Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
title_sort correction: gene expression profiling identifies fyn as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056636/
https://www.ncbi.nlm.nih.gov/pubmed/31712727
http://dx.doi.org/10.1038/s41388-019-1096-8
work_keys_str_mv AT eliasd correctiongeneexpressionprofilingidentifiesfynasanimportantmoleculeintamoxifenresistanceandapredictorofearlyrecurrenceinpatientstreatedwithendocrinetherapy
AT veverh correctiongeneexpressionprofilingidentifiesfynasanimportantmoleculeintamoxifenresistanceandapredictorofearlyrecurrenceinpatientstreatedwithendocrinetherapy
AT lænkholmav correctiongeneexpressionprofilingidentifiesfynasanimportantmoleculeintamoxifenresistanceandapredictorofearlyrecurrenceinpatientstreatedwithendocrinetherapy
AT gjerstorffmf correctiongeneexpressionprofilingidentifiesfynasanimportantmoleculeintamoxifenresistanceandapredictorofearlyrecurrenceinpatientstreatedwithendocrinetherapy
AT ydecw correctiongeneexpressionprofilingidentifiesfynasanimportantmoleculeintamoxifenresistanceandapredictorofearlyrecurrenceinpatientstreatedwithendocrinetherapy
AT lykkesfeldtae correctiongeneexpressionprofilingidentifiesfynasanimportantmoleculeintamoxifenresistanceandapredictorofearlyrecurrenceinpatientstreatedwithendocrinetherapy
AT ditzelhj correctiongeneexpressionprofilingidentifiesfynasanimportantmoleculeintamoxifenresistanceandapredictorofearlyrecurrenceinpatientstreatedwithendocrinetherapy